Hepatorenal Syndrome: Clinical Trials

48 trials for Hepatorenal Syndrome, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

24 completed, 7 unknown, 5 recruiting, 5 terminated. 14 Phase 2, 12 Not applicable, 11 Phase 3, 3 Phase 4, 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 214Completed 6, Terminated 2, Unknown 2, Withdrawn 2, Active not recruiting 1, Recruiting 1
Not applicable12Completed 5, Recruiting 2, Terminated 2, Not yet recruiting 1, Suspended 1, Withdrawn 1
Phase 311Completed 8, Terminated 2, Recruiting 1
Phase 43Completed 1, Suspended 1, Unknown 1
Phase 12Completed 1, Terminated 1
Early Phase 11Completed 1

Follow Hepatorenal Syndrome: new trials by email Literature Review of Hepatorenal Syndrome trials Research Report on Hepatorenal Syndrome

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Renal Histopathology and Transcriptomic Analysis in Hepatorenal Syndrome During Liver Transplantation
renal biopsy - Hepatorenal Syndrome, Liver Regeneration, AKI - Acute Kidney Injury
Not applicableNot yet recruitingThe University of Hong Kong422026-01-012025-12-24
Comparison of Terlipressin Versus Octreotide in Patients With Hepatorenal Syndrome
terlipressin, Octreotide (drug) - Hepatorenal Syndrome
Not applicableCompletedLahore General Hospital602025-05-012026-03-10
Initial Resuscitation for Acute Kidney Injury in Cirrhosis
Recommendation: No Further Resuscitation, Recommendation: Resuscitation with Crystalloid, Recommendation: Resuscitation with Colloid - Cirrhosis, Liver, Acute Kidney Injury
Not applicableRecruitingMassachusetts General Hospital502024-09-122026-03-13
Endothelin Receptor Antagonism With Ambrisentan to Treat Hepatorenal Syndrome
Ambrisentan, Terlipressin - Hepatorenal Syndrome, Liver Cirrhosis
Phase 2Active not recruitingNoorik Biopharmaceuticals AG542024-04-172026-04-13
Terlipressin in Combined Hepatorenal Syndrome in Patients With Signs of Chronic Renal Disease
terlipressin or noradrenalin plus albumin - Liver Cirrhosis, Hepato-Renal Syndrome
CompletedUniversity Hospital Freiburg4902024-03-032025-12-05
NEPH-ROSIS (NEPHrology in CirRhOSIS) Pilot Trial: A Trial to Treat Acute Kidney Injury Among Hospitalized Cirrhosis Patients
MAP-Target Algorithm - Acute Kidney Injury, Cirrhosis
Phase 2 / Phase 3TerminatedUniversity of California, San Francisco142024-02-012026-09-24
Study to Evaluate R2R01 Plus Terlipressin Versus Terlipressin Alone in Patients With Hepatorenal Syndrome
R2R01, Terlipressin - Hepatorenal Syndrome, Acute Kidney Injury
Phase 2UnknownRiver 2 Renal Corp.952023-06-302023-10-03
A Retrospective Analysis of Outcomes in Patients With Hepatorenal Syndrome at Methodist Dallas Medical Center
Hepatorenal Syndrome outcome in Patients at Methodist Health systems - Hepatorenal Syndrome
RecruitingMethodist Health System5002023-05-132026-05-01
HRS-AKI Treatment With TIPS in Patients With Cirrhosis
TIPS, Standard of Care - Cirrhosis, Liver, Hepatorenal Syndrome
Not applicableRecruitingJena University Hospital1242022-11-292024-11-18
International Registry of Acute Kidney Injury in Cirrhosis: The GLOBAL AKI Project
Crystalloids, albumin, vasoconstrictors, diuretics, renal replacement therapy - Liver Cirrhosis, Acute Kidney Injury
CompletedAzienda Ospedaliera di Padova14562022-07-012024-01-30
Statin Impact on Hepatic Decompensation
Atorvastatin 20mg, Placebo - Quality of Life, the Incidence of Whole Complications Resultant From Decompensated Liver
Phase 2 / Phase 3CompletedTanta University1002022-06-152026-09-14
The Selective Cytopheretic Device (SCD) for Acute Kidney Injury (AKI) and Hepatorenal Syndrome (HRS) Type I
Selective Cytopheretic Device - Acute Kidney Injury, Hepatorenal Syndrome
Not applicableSuspendedLenar Yessayan102022-06-092026-10-02
A Study of OCE-205 in Participants With Cirrhosis With Ascites Who Developed Hepatorenal Syndrome-Acute Kidney Injury
OCE-205, Placebo - Cirrhosis, Ascites
Phase 2CompletedOcelot Bio, Inc472022-04-282023-12-15
Point-of-Care Echocardiography to Assess Impact of Dynamic Cardiac Function, Renal and Cardiac Biomarkers in Cirrhosis With Hepatorenal Syndrome-Acute Kidney Injury
Echocardiographic assessment - Hepatorenal Syndrome, Cirrhosis, Liver
UnknownPost Graduate Institute of Medical Education and Research, Chandigarh752021-12-152023-05-01
Fractional Excretion of Urea for the Differential Diagnosis of Acute Kidney Injury in Cirrhosis
Acute Kidney Injury
UnknownSohag University1002021-09-042022-10-28
Angiotensin 2 for Hepatorenal Syndrome
Angiotensin II, Midodrine, Octreotide - Hepatorenal Syndrome, Cirrhosis
Phase 2WithdrawnUniversity of California, Los Angeles2021-07-012024-03-06
Faecal Microbiota Transplantation for Liver Cirrhosis
Faecal microbiota transplantation, Placebo - Liver Cirrhosis
Phase 2 / Phase 3RecruitingUniversity of Aarhus2202021-07-012025-01-24
Terlipressin for HRS-AKI in Liver Transplant Candidates (INFUSE)
Terlipressin - Hepatorenal Syndrome
Phase 3CompletedUniversity of Pennsylvania502020-12-112024-10-09
Efficacy of Early Terlipressin Plus Albumin Therapy in Comparison to Standard Treatment for HRS-AKI in Acute-on-chronic Liver Failure.
Terlipressin, Albumin - Acute-On-Chronic Liver Failure, Hepatorenal Syndrome
Not applicableCompletedInstitute of Liver and Biliary Sciences, India702020-06-222023-04-06
Nor-epinephrine Versus Midodrine/Octreotide in Patients With Hepatorenal Syndrome
Midodrine/Octreotide, Nor-epinephrine - Hepato-Renal Syndrome
Not applicableCompletedNational Hepatology & Tropical Medicine Research Institute912018-04-152020-08-21

Showing 20 of 48. Sign in to see all of them.

Narrower conditions

Fibrosis (20)  ·  Acute Kidney Injury (18)  ·  Ascites (10)  ·  Liver Cirrhosis (10)  ·  Renal Insufficiency (6)  ·  Hypertension, Portal (4)  ·  Acute-On-Chronic Liver Failure (3)  ·  Hepatitis, Alcoholic (3)  ·  Liver Diseases (3)  ·  Kidney Cortex Necrosis (2)  ·  Adrenal Insufficiency (1)  ·  Brain Diseases (1)  ·  Gastrointestinal Hemorrhage (1)  ·  Hepatic Encephalopathy (1)

Broader conditions

Digestive System Diseases (48)  ·  Female Urogenital Diseases (48)  ·  Female Urogenital Diseases and Pregnancy Complications (48)  ·  Kidney Diseases (48)  ·  Male Urogenital Diseases (48)  ·  Urogenital Diseases (48)  ·  Urologic Diseases (48)  ·  Liver Diseases (45)  ·  Pathologic Processes (28)  ·  Pathological Conditions, Signs and Symptoms (28)  ·  Renal Insufficiency (18)  ·  Fibrosis (8)  ·  Hepatic Insufficiency (4)  ·  Liver Failure (4)  ·  Alcohol-Induced Disorders (3)

Interventions

Terlipressin (16)  ·  Albumins (9)  ·  Midodrine (6)  ·  Octreotide (6)  ·  Crystalloid Solutions (2)  ·  Norepinephrine (2)  ·  Amoxicillin (1)  ·  Amoxicillin-Potassium Clavulanate Combination (1)  ·  Angiotensin I (1)  ·  Angiotensin II (1)  ·  Atorvastatin (1)  ·  Blood Specimen Collection (1)  ·  Colloids (1)  ·  Diuretics (1)  ·  Fecal Microbiota Transplantation (1)

Sponsors

Hospital Clinic of Barcelona (4)  ·  Mallinckrodt (3)  ·  Institute of Liver and Biliary Sciences, India (2)  ·  The University of Hong Kong (2)  ·  University of Turin, Italy (2)  ·  Anna Cruceta (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Azienda Ospedaliera di Padova (1)  ·  Cumberland Pharmaceuticals (1)  ·  Hospices Civils de Lyon (1)  ·  Hvidovre University Hospital (1)  ·  Jena University Hospital (1)  ·  La Jolla Pharmaceutical Company (1)  ·  Lahey Clinic (1)  ·  Lahore General Hospital (1)

Countries

United States (16)  ·  India (6)  ·  Spain (6)  ·  Canada (4)  ·  Egypt (4)  ·  France (4)  ·  Italy (4)  ·  Denmark (3)  ·  Germany (3)  ·  Brazil (2)  ·  China (2)  ·  Hong Kong (2)  ·  South Korea (2)  ·  Argentina (1)  ·  Austria (1)

Top investigators

Alberto Q Farias, Associate professor (1)  ·  Arun J. Sanyal, M.D. (1)  ·  Brendan McGuire, MD (1)  ·  Carlo Alessandria, MD (1)  ·  Cristina Ripoll, MD (1)  ·  Cristina Ripoll, Prof. Dr. (1)  ·  Desmond Yap, MD (1)  ·  Dominik Bettinger, MD (1)  ·  Edith Fleischmann, M.D. (1)  ·  Eman A Sabet, Professor (1)

Results publications

PMID 36633470, PMID 37143199, PMID 37302573, PMID 40704461, PMID 25638527, PMID 28370090, PMID 17560680, PMID 18471513, PMID 22521351, PMID 24277679, PMID 24375576, PMID 24613364, PMID 24700173, PMID 25183658, PMID 26042740, PMID 26141259, PMID 26484442, PMID 26896734, PMID 27464593, PMID 27475248, PMID 27876501, PMID 28406940, PMID 28842294, PMID 29140542, PMID 29369449, PMID 29973706, PMID 31096099, PMID 33657294, PMID 37020315, PMID 37159035, PMID 37976391, PMID 38235907, PMID 39938959, PMID 40058397, PMID 40658810, PMID 40677691, PMID 41200852, PMID 41265546, PMID 41865069, PMID 42813964

NIH funding

2014 (1), K23DK128567 (1)